Literature DB >> 31235099

High prevalence of insulin resistance and occurrence prior to hyperinsulinemia threshold among people living with HIV in Pune, India.

Ivan Marbaniang1, Shashikala Sangle2, Sonali Salvi2, Vandana Kulkarni3, Dhananjay Shere3, Prasad Deshpande3, Smita Nimkar3, Amita Gupta4, Vidya Mave5.   

Abstract

BACKGROUND: Diabetes prevalence in HIV is not well characterized for India, despite the high burden of both individual diseases. Epidemiology of insulin resistance (IR): a precursor to diabetes, and its associated risk factors are also poorly understood in Asian Indian people living with HIV (PLHIV). We assessed the prevalence of diabetes and IR in Pune, India and the associated risk factors for IR.
METHODS: Cross-sectional analysis of adult (≥18 years) PLHIV receiving care at Byramjee Jeejeebhoy Government Medical College and Sassoon General Hospitals, Pune, India (BJGMC- SGH). Proportions and medians of PLHIV characteristics by diabetes status and IR were described. Homeostatic Model Assessment (HOMA) index value ≥2 was used to define IR. Line of least squares assessed the relationship between IR and hyperinsulinemia. Association between sociodemographic, clinical factors with IR was determined using logistic regression.
RESULTS: Of 485 enrollees, 47% were men, median age was 40 years (IQR: 35-46), median CD4 counts were 389 cells/mm3 (246-609). Thirty-five percent were centrally obese, 75% were adherent to WHO recommended physical activity guidelines. Prevalence of diabetes, prediabetes, IR were 9%, 16% and 38%, respectively. Twenty-nine percent non-diabetics had IR and it occurred much prior to the threshold for hyperinsulinemia. IR was associated with the use of ART drugs (OR: 6.6, 95% CI: 2.9-15.2 and 5.4, 95% CI: 2.2-13.6 for first- and second line ART respectively) and central obesity (OR:1.9, 95% CI: 1.1-3.4).
CONCLUSIONS: One fourth of the study population was diabetic or prediabetic and more than a third had IR. Better understanding of diabetes disease progression in relation to IR and the effect of physical activity on central obesity among Asian Indian PLHIV is mandated.
Copyright © 2019 Diabetes India. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31235099      PMCID: PMC6597186          DOI: 10.1016/j.dsx.2019.04.009

Source DB:  PubMed          Journal:  Diabetes Metab Syndr        ISSN: 1871-4021


  24 in total

1.  Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study.

Authors:  R M Anjana; R Pradeepa; M Deepa; M Datta; V Sudha; R Unnikrishnan; A Bhansali; S R Joshi; P P Joshi; C S Yajnik; V K Dhandhania; L M Nath; A K Das; P V Rao; S V Madhu; D K Shukla; T Kaur; M Priya; E Nirmal; S J Parvathi; S Subhashini; R Subashini; M K Ali; V Mohan
Journal:  Diabetologia       Date:  2011-09-30       Impact factor: 10.122

2.  Peripheral and central fat changes in subjects randomized to abacavir-lamivudine or tenofovir-emtricitabine with atazanavir-ritonavir or efavirenz: ACTG Study A5224s.

Authors:  Grace A McComsey; Douglas Kitch; Paul E Sax; Pablo Tebas; Camlin Tierney; Nasreen C Jahed; Laurie Myers; Kathleen Melbourne; Belinda Ha; Eric S Daar
Journal:  Clin Infect Dis       Date:  2011-07-15       Impact factor: 9.079

3.  Body fat distribution and insulin resistance in healthy Asian Indians and Caucasians.

Authors:  A Raji; E W Seely; R A Arky; D C Simonson
Journal:  J Clin Endocrinol Metab       Date:  2001-11       Impact factor: 5.958

4.  Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the Multicenter AIDS Cohort Study.

Authors:  Todd T Brown; Xiuhong Li; Stephen R Cole; Lawrence A Kingsley; Frank J Palella; Sharon A Riddler; Joan S Chmiel; Barbara R Visscher; Joseph B Margolick; Adrian S Dobs
Journal:  AIDS       Date:  2005-09-02       Impact factor: 4.177

5.  Prevalence of insulin resistance syndrome in a selected south Indian population--the Chennai urban population study-7 [CUPS-7].

Authors:  R Deepa; C S Shanthirani; G Premalatha; N G Sastry; V Mohan
Journal:  Indian J Med Res       Date:  2002-03       Impact factor: 2.375

6.  Antiretroviral therapy exposure and insulin resistance in the Women's Interagency HIV study.

Authors:  Phyllis C Tien; Michael F E Schneider; Stephen R Cole; Alexandra M Levine; Mardge Cohen; Jack DeHovitz; Mary Young; Jessica E Justman
Journal:  J Acquir Immune Defic Syndr       Date:  2008-12-01       Impact factor: 3.731

Review 7.  Prevalence and pathogenesis of diabetes mellitus in HIV-1 infection treated with combined antiretroviral therapy.

Authors:  Katherine Samaras
Journal:  J Acquir Immune Defic Syndr       Date:  2009-04-15       Impact factor: 3.731

Review 8.  HIV-1, reactive oxygen species, and vascular complications.

Authors:  Kristi M Porter; Roy L Sutliff
Journal:  Free Radic Biol Med       Date:  2012-04-21       Impact factor: 7.376

9.  Insulin resistance and vascular dysfunction in nondiabetic Asian Indians.

Authors:  Annaswamy Raji; Marie D Gerhard-Herman; Mercedes Warren; Stuart G Silverman; Vassilios Raptopoulos; Christos S Mantzoros; Donald C Simonson
Journal:  J Clin Endocrinol Metab       Date:  2004-08       Impact factor: 5.958

10.  South Asian Consensus Guidelines for the rational management of diabetes in human immunodeficiency virus/acquired immunodeficiency syndrome.

Authors:  Sanjay Kalra; Ambika Gopalakrishnan Unnikrishnan; Syed Abbas Raza; Ganpathy Bantwal; Manash P Baruah; Tint Swe Latt; Dina Shrestha; Mathew John; Prasad Katulanda; Noel Somasundaram; Rakesh Sahay; Faruque Pathan
Journal:  Indian J Endocrinol Metab       Date:  2011-10
View more
  2 in total

1.  The Burden of Anxiety During the COVID-19 Pandemic Among People Living with HIV (PLHIV) in Pune, India.

Authors:  Ivan Marbaniang; Shashikala Sangle; Smita Nimkar; Kanta Zarekar; Sonali Salvi; Amol Chavan; Amita Gupta; Nishi Suryavanshi; Vidya Mave
Journal:  Res Sq       Date:  2020-08-13

2.  The burden of anxiety among people living with HIV during the COVID-19 pandemic in Pune, India.

Authors:  Ivan Marbaniang; Shashikala Sangle; Smita Nimkar; Kanta Zarekar; Sonali Salvi; Amol Chavan; Amita Gupta; Nishi Suryavanshi; Vidya Mave
Journal:  BMC Public Health       Date:  2020-10-23       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.